Sandrine Egron

Sandrine Egron is an accomplished Investment Director at 50 Partners Health, focusing on a diverse portfolio of health companies. With a strong background in digital health, Sandrine co-founded InnYTe to improve chronic disease management in fast-developing countries and served as a CEO Transition Advisor. Experience includes roles as Chief Operating Officer at Susu, Leader of the Innovative Health Group at French Healthcare Vietnam, and co-founder of Vivosim, which specializes in AI-driven oncology solutions. Sandrine has also worked as an R&D Project Manager at RWTH Aachen University, managing cardiovascular product development, and held a Business Development Manager position at NALYS. Educational qualifications include a PhD in Medical Sciences from RWTH Aachen University and Master's degrees in Biomedical Engineering and the T.I.M.E. network.